You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

HALCION Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Halcion, and what generic alternatives are available?

Halcion is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in HALCION is triazolam. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the triazolam profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Halcion

A generic version of HALCION was approved as triazolam by NOVAST LABS on October 20th, 2020.

  Try a Trial

Drug patent expirations by year for HALCION
Drug Prices for HALCION

See drug prices for HALCION

Recent Clinical Trials for HALCION

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Boston Medical CenterPhase 4
Akili Interactive Labs, Inc.N/A
Investigación Farmacológica y BiofarmacéuticaPhase 1

See all HALCION clinical trials

Pharmacology for HALCION
Drug ClassBenzodiazepine
Anatomical Therapeutic Chemical (ATC) Classes for HALCION

US Patents and Regulatory Information for HALCION

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer HALCION triazolam TABLET;ORAL 017892-003 Apr 26, 1985 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer HALCION triazolam TABLET;ORAL 017892-001 Nov 15, 1982 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer HALCION triazolam TABLET;ORAL 017892-002 Nov 15, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for HALCION

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer HALCION triazolam TABLET;ORAL 017892-001 Nov 15, 1982 ⤷  Try a Trial ⤷  Try a Trial
Pfizer HALCION triazolam TABLET;ORAL 017892-001 Nov 15, 1982 ⤷  Try a Trial ⤷  Try a Trial
Pfizer HALCION triazolam TABLET;ORAL 017892-002 Nov 15, 1982 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.